Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease

Background: The etiology of cerebral small vessel disease (SVD) remains elusive, though evidence is accumulating that inflammation contributes to its pathophysiology. We recently showed retrospectively that pro-inflammatory monocytes are associated with the long-term progression of white matter hype...

Full description

Bibliographic Details
Main Authors: Marlies P. Noz, Annemieke ter Telgte, Kim Wiegertjes, Anil M. Tuladhar, Charlotte Kaffa, Simone Kersten, Siroon Bekkering, Charlotte D. C. C. van der Heijden, Alexander Hoischen, Leo A. B. Joosten, Mihai G. Netea, Marco Duering, Frank-Erik de Leeuw, Niels P. Riksen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.639361/full
id doaj-cb681f1b1f4042ff8dd4e7a06c198ac4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Marlies P. Noz
Annemieke ter Telgte
Kim Wiegertjes
Anil M. Tuladhar
Charlotte Kaffa
Simone Kersten
Simone Kersten
Siroon Bekkering
Charlotte D. C. C. van der Heijden
Alexander Hoischen
Alexander Hoischen
Leo A. B. Joosten
Leo A. B. Joosten
Mihai G. Netea
Mihai G. Netea
Marco Duering
Marco Duering
Marco Duering
Frank-Erik de Leeuw
Niels P. Riksen
spellingShingle Marlies P. Noz
Annemieke ter Telgte
Kim Wiegertjes
Anil M. Tuladhar
Charlotte Kaffa
Simone Kersten
Simone Kersten
Siroon Bekkering
Charlotte D. C. C. van der Heijden
Alexander Hoischen
Alexander Hoischen
Leo A. B. Joosten
Leo A. B. Joosten
Mihai G. Netea
Mihai G. Netea
Marco Duering
Marco Duering
Marco Duering
Frank-Erik de Leeuw
Niels P. Riksen
Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
Frontiers in Cardiovascular Medicine
cerebral small vessel disease
magnetic resonance imaging
innate immunity
monocyte
inflammation
author_facet Marlies P. Noz
Annemieke ter Telgte
Kim Wiegertjes
Anil M. Tuladhar
Charlotte Kaffa
Simone Kersten
Simone Kersten
Siroon Bekkering
Charlotte D. C. C. van der Heijden
Alexander Hoischen
Alexander Hoischen
Leo A. B. Joosten
Leo A. B. Joosten
Mihai G. Netea
Mihai G. Netea
Marco Duering
Marco Duering
Marco Duering
Frank-Erik de Leeuw
Niels P. Riksen
author_sort Marlies P. Noz
title Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
title_short Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
title_full Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
title_fullStr Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
title_full_unstemmed Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
title_sort pro-inflammatory monocyte phenotype during acute progression of cerebral small vessel disease
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-05-01
description Background: The etiology of cerebral small vessel disease (SVD) remains elusive, though evidence is accumulating that inflammation contributes to its pathophysiology. We recently showed retrospectively that pro-inflammatory monocytes are associated with the long-term progression of white matter hyperintensities (WMHs). In this prospective high-frequency imaging study, we hypothesize that the incidence of SVD progression coincides with a pro-inflammatory monocyte phenotype.Methods: Individuals with SVD underwent monthly magnetic resonance imaging (MRI) for 10 consecutive months to detect SVD progression, defined as acute diffusion-weighted imaging-positive (DWI+) lesions, incident microbleeds, incident lacunes, and WMH progression. Circulating inflammatory markers were measured, cytokine production capacity of monocytes was assessed after ex vivo stimulation, and RNA sequencing was performed on isolated monocytes in a subset of participants.Results: 13 out of 35 individuals developed SVD progression (70 ± 6 years, 54% men) based on incident lesions (n = 7) and/or upper quartile WMH progression (n = 9). Circulating E-selectin concentration (p < 0.05) and the cytokine production capacity of interleukin (IL)-1β and IL-6 (p < 0.01) were higher in individuals with SVD progression. Moreover, RNA sequencing revealed a pro-inflammatory monocyte signature including genes involved in myelination, blood–brain barrier, and endothelial–leukocyte interaction.Conclusions: Circulating monocytes of individuals with progressive SVD have an inflammatory phenotype, characterized by an increased cytokine production capacity and a pro-inflammatory transcriptional signature.
topic cerebral small vessel disease
magnetic resonance imaging
innate immunity
monocyte
inflammation
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.639361/full
work_keys_str_mv AT marliespnoz proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT annemieketertelgte proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT kimwiegertjes proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT anilmtuladhar proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT charlottekaffa proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT simonekersten proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT simonekersten proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT siroonbekkering proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT charlottedccvanderheijden proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT alexanderhoischen proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT alexanderhoischen proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT leoabjoosten proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT leoabjoosten proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT mihaignetea proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT mihaignetea proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT marcoduering proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT marcoduering proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT marcoduering proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT frankerikdeleeuw proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
AT nielspriksen proinflammatorymonocytephenotypeduringacuteprogressionofcerebralsmallvesseldisease
_version_ 1721442937582125056
spelling doaj-cb681f1b1f4042ff8dd4e7a06c198ac42021-05-13T04:29:05ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-05-01810.3389/fcvm.2021.639361639361Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel DiseaseMarlies P. Noz0Annemieke ter Telgte1Kim Wiegertjes2Anil M. Tuladhar3Charlotte Kaffa4Simone Kersten5Simone Kersten6Siroon Bekkering7Charlotte D. C. C. van der Heijden8Alexander Hoischen9Alexander Hoischen10Leo A. B. Joosten11Leo A. B. Joosten12Mihai G. Netea13Mihai G. Netea14Marco Duering15Marco Duering16Marco Duering17Frank-Erik de Leeuw18Niels P. Riksen19Department of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, NetherlandsCenter for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsDepartment for Genomics and Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Bonn, GermanyDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, NetherlandsInstitute for Stroke and Dementia Research, University Hospital of Munich, Munich, GermanyMunich Cluster for Systems Neurology, Munich, GermanyDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, NetherlandsBackground: The etiology of cerebral small vessel disease (SVD) remains elusive, though evidence is accumulating that inflammation contributes to its pathophysiology. We recently showed retrospectively that pro-inflammatory monocytes are associated with the long-term progression of white matter hyperintensities (WMHs). In this prospective high-frequency imaging study, we hypothesize that the incidence of SVD progression coincides with a pro-inflammatory monocyte phenotype.Methods: Individuals with SVD underwent monthly magnetic resonance imaging (MRI) for 10 consecutive months to detect SVD progression, defined as acute diffusion-weighted imaging-positive (DWI+) lesions, incident microbleeds, incident lacunes, and WMH progression. Circulating inflammatory markers were measured, cytokine production capacity of monocytes was assessed after ex vivo stimulation, and RNA sequencing was performed on isolated monocytes in a subset of participants.Results: 13 out of 35 individuals developed SVD progression (70 ± 6 years, 54% men) based on incident lesions (n = 7) and/or upper quartile WMH progression (n = 9). Circulating E-selectin concentration (p < 0.05) and the cytokine production capacity of interleukin (IL)-1β and IL-6 (p < 0.01) were higher in individuals with SVD progression. Moreover, RNA sequencing revealed a pro-inflammatory monocyte signature including genes involved in myelination, blood–brain barrier, and endothelial–leukocyte interaction.Conclusions: Circulating monocytes of individuals with progressive SVD have an inflammatory phenotype, characterized by an increased cytokine production capacity and a pro-inflammatory transcriptional signature.https://www.frontiersin.org/articles/10.3389/fcvm.2021.639361/fullcerebral small vessel diseasemagnetic resonance imaginginnate immunitymonocyteinflammation